| Home |
Elanco Joins as New OA Realizing the benefits and value of partnering with AOAC in its validation efforts, Elanco Animal Health, A Division of Eli Lilly and Co. (Greenfield, Indiana, USA) joined in May as AOAC’s newest Organizational Affiliate (OA). The company saw first-hand what AOAC does and does best—bring relevant and diverse groups of stakeholders together to come to consensus on fit-for-purpose methodology, a process important to their efforts with AOAC to validate globally accepted methodology for detection of various animal drug residues in tissues. Indeed, AOAC has a proven track record (National Institutes of Health, Pepsi/Coke, Department of Homeland Security) of providing science-based solutions by bringing together key stakeholders to develop, evaluate, and validate consensus-based analytical methods. For more information on the OA program, contact Dawn Frazier at dfrazier@aoac.org or Anita Mishra at amishra@aoac.org. To become a member of AOAC, visit http://www.aoac.org/membership/joinindividual.html
|
